Molecules

Name	Type	Specific against	Appl.	Item no.	Amount	Price
NMS-P937 (NMS1286937)	Inhibitors	Other		DCC-DC8445-250mg DCChemicals	250 mg	Login Compare	NMS-P937 (NMS1286937)
α-Amyloid Precursor Protein Modulator(TPPB)	Chemicals	Other		DCC-DC8534-25mg DCChemicals	25 mg	Login Compare	α-Amyloid Precursor Protein Modulator(TPPB)
NMS-P937 (NMS1286937)	Inhibitors	Other		DCC-DC8445-1g DCChemicals	1 g	Login Compare	NMS-P937 (NMS1286937)
α-Amyloid Precursor Protein Modulator(TPPB)	Chemicals	Other		DCC-DC8534-50mg DCChemicals	50 mg	Login Compare	α-Amyloid Precursor Protein Modulator(TPPB)
Lefamulin(BC-3781)	Chemicals	Other		DCC-DC8172-25mg DCChemicals	25 mg	Login Compare	Lefamulin(BC-3781)
Z-VAD(OH)-FMK	Chemicals	Other		DCC-DC8639-250mg DCChemicals	250 mg	Login Compare	Z-VAD(OH)-FMK
4SC-202 free base	Inhibitors	Other		DCC-DC8423-100mg DCChemicals	100 mg	Login Compare	4SC-202 free base
4SC-202 free base	Inhibitors	Other		DCC-DC8423-250mg DCChemicals	250 mg	Login Compare	4SC-202 free base
4SC-202 free base	Inhibitors	Other		DCC-DC8423-1g DCChemicals	1 g	Login Compare	4SC-202 free base
Ensifentrine	Chemicals	Other	Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC50s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research[1][2].	DCC-DC82103-100mg DCChemicals	100 mg	Login Compare	Ensifentrine
Ensifentrine	Chemicals	Other	Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC50s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research[1][2].	DCC-DC82103-250mg DCChemicals	250 mg	Login Compare	Ensifentrine
Ensifentrine	Chemicals	Other	Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC50s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research[1][2].	DCC-DC82103-1g DCChemicals	1 g	Login Compare	Ensifentrine
BRD4/CK2-IN-1	Chemicals	Other	BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC50s of 180 nM and 230 nM for BRD4 and CK2, respectively. BRD4/CK2-IN-1 has strong anticancer activity without obvious toxicities. BRD4/CK2-IN-1 induces apoptosis and autophagy-associated cell death in triple-negative breast cancer (TNBC)[1]	DCC-DC80106-100mg DCChemicals	100 mg	Login Compare	BRD4/CK2-IN-1
BRD4/CK2-IN-1	Chemicals	Other	BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC50s of 180 nM and 230 nM for BRD4 and CK2, respectively. BRD4/CK2-IN-1 has strong anticancer activity without obvious toxicities. BRD4/CK2-IN-1 induces apoptosis and autophagy-associated cell death in triple-negative breast cancer (TNBC)[1]	DCC-DC80106-250mg DCChemicals	250 mg	Login Compare	BRD4/CK2-IN-1
BRD4/CK2-IN-1	Chemicals	Other	BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC50s of 180 nM and 230 nM for BRD4 and CK2, respectively. BRD4/CK2-IN-1 has strong anticancer activity without obvious toxicities. BRD4/CK2-IN-1 induces apoptosis and autophagy-associated cell death in triple-negative breast cancer (TNBC)[1]	DCC-DC80106-1g DCChemicals	1 g	Login Compare	BRD4/CK2-IN-1
VH032-cyclopropane-F	Chemicals	Other	ELISA, other	DCC-DC86101-100mg DCChemicals	100 mg	Login Compare	VH032-cyclopropane-F
VH032-cyclopropane-F	Chemicals	Other	ELISA, other	DCC-DC86101-250mg DCChemicals	250 mg	Login Compare	VH032-cyclopropane-F
VH032-cyclopropane-F	Chemicals	Other	ELISA, other	DCC-DC86101-1g DCChemicals	1 g	Login Compare	VH032-cyclopropane-F
MS48107	Chemicals	Other	MS	DCC-DC80088-25mg DCChemicals	25 mg	Login Compare	MS48107
(S)-PFI-2 HCl	Chemicals	Other	Negative control of (R)-PFI 2 hydrochloride. Exhibits 500-fold lower activity in a SETD7 enzymatic assay (IC50 = 1 μM) compared to the active enantiomer.	DCC-DC8290-5mg DCChemicals	5 mg	Login Compare	(S)-PFI-2 HCl
8-Bromo-cAMP	Chemicals	Other	8-Bromo-cAMP is a cell perbeable cyclic AMP (cAMP) analog and a PKA activator.	DCC-DC8388-100mg DCChemicals	100 mg	Login Compare	8-Bromo-cAMP
8-Bromo-cAMP	Chemicals	Other	8-Bromo-cAMP is a cell perbeable cyclic AMP (cAMP) analog and a PKA activator.	DCC-DC8388-250mg DCChemicals	250 mg	Login Compare	8-Bromo-cAMP
8-Bromo-cAMP	Chemicals	Other	8-Bromo-cAMP is a cell perbeable cyclic AMP (cAMP) analog and a PKA activator.	DCC-DC8388-1g DCChemicals	1 g	Login Compare	8-Bromo-cAMP
Mavatrep(JNJ-39439335)	Chemicals	Other	Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 μM) of CYP isoforms 3A4, 1A2, and 2D6.	DCC-DC8378-100mg DCChemicals	100 mg	Login Compare	Mavatrep(JNJ-39439335)
Mavatrep(JNJ-39439335)	Chemicals	Other	Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 μM) of CYP isoforms 3A4, 1A2, and 2D6.	DCC-DC8378-250mg DCChemicals	250 mg	Login Compare	Mavatrep(JNJ-39439335)

Name Price

NMS-P937 (NMS1286937)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8445-250mg
Amount	250 mg
Available

α-Amyloid Precursor Protein Modulator(TPPB)

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8534-25mg
Amount	25 mg
Available

NMS-P937 (NMS1286937)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8445-1g
Amount	1 g
Available

α-Amyloid Precursor Protein Modulator(TPPB)

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8534-50mg
Amount	50 mg
Available

Lefamulin(BC-3781)

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8172-25mg
Amount	25 mg
Available

Z-VAD(OH)-FMK

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8639-250mg
Amount	250 mg
Available

4SC-202 free base

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8423-100mg
Amount	100 mg
Available

4SC-202 free base

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8423-250mg
Amount	250 mg
Available

4SC-202 free base

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC8423-1g
Amount	1 g
Available

Ensifentrine

Type	Chemicals
Clone
Specific against	Other
Appl.	Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC50s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research[1][2].
Host
Item no.	DCC-DC82103-100mg
Amount	100 mg
Available

Ensifentrine

Type	Chemicals
Clone
Specific against	Other
Appl.	Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC50s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research[1][2].
Host
Item no.	DCC-DC82103-250mg
Amount	250 mg
Available

Ensifentrine

Type	Chemicals
Clone
Specific against	Other
Appl.	Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC50s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research[1][2].
Host
Item no.	DCC-DC82103-1g
Amount	1 g
Available

BRD4/CK2-IN-1

Type	Chemicals
Clone
Specific against	Other
Appl.	BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC50s of 180 nM and 230 nM for BRD4 and CK2, respectively. BRD4/CK2-IN-1 has strong anticancer activity without obvious toxicities. BRD4/CK2-IN-1 induces apoptosis and autophagy-associated cell death in triple-negative breast cancer (TNBC)[1]
Host
Item no.	DCC-DC80106-100mg
Amount	100 mg
Available

BRD4/CK2-IN-1

Type	Chemicals
Clone
Specific against	Other
Appl.	BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC50s of 180 nM and 230 nM for BRD4 and CK2, respectively. BRD4/CK2-IN-1 has strong anticancer activity without obvious toxicities. BRD4/CK2-IN-1 induces apoptosis and autophagy-associated cell death in triple-negative breast cancer (TNBC)[1]
Host
Item no.	DCC-DC80106-250mg
Amount	250 mg
Available

BRD4/CK2-IN-1

Type	Chemicals
Clone
Specific against	Other
Appl.	BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC50s of 180 nM and 230 nM for BRD4 and CK2, respectively. BRD4/CK2-IN-1 has strong anticancer activity without obvious toxicities. BRD4/CK2-IN-1 induces apoptosis and autophagy-associated cell death in triple-negative breast cancer (TNBC)[1]
Host
Item no.	DCC-DC80106-1g
Amount	1 g
Available

VH032-cyclopropane-F

Type	Chemicals
Clone
Specific against	Other
Appl.	ELISA, other
Host
Item no.	DCC-DC86101-100mg
Amount	100 mg
Available

VH032-cyclopropane-F

Type	Chemicals
Clone
Specific against	Other
Appl.	ELISA, other
Host
Item no.	DCC-DC86101-250mg
Amount	250 mg
Available

VH032-cyclopropane-F

Type	Chemicals
Clone
Specific against	Other
Appl.	ELISA, other
Host
Item no.	DCC-DC86101-1g
Amount	1 g
Available

MS48107

Type	Chemicals
Clone
Specific against	Other
Appl.	MS
Host
Item no.	DCC-DC80088-25mg
Amount	25 mg
Available

(S)-PFI-2 HCl

Type	Chemicals
Clone
Specific against	Other
Appl.	Negative control of (R)-PFI 2 hydrochloride. Exhibits 500-fold lower activity in a SETD7 enzymatic assay (IC50 = 1 μM) compared to the active enantiomer.
Host
Item no.	DCC-DC8290-5mg
Amount	5 mg
Available

8-Bromo-cAMP

Type	Chemicals
Clone
Specific against	Other
Appl.	8-Bromo-cAMP is a cell perbeable cyclic AMP (cAMP) analog and a PKA activator.
Host
Item no.	DCC-DC8388-100mg
Amount	100 mg
Available

8-Bromo-cAMP

Type	Chemicals
Clone
Specific against	Other
Appl.	8-Bromo-cAMP is a cell perbeable cyclic AMP (cAMP) analog and a PKA activator.
Host
Item no.	DCC-DC8388-250mg
Amount	250 mg
Available

8-Bromo-cAMP

Type	Chemicals
Clone
Specific against	Other
Appl.	8-Bromo-cAMP is a cell perbeable cyclic AMP (cAMP) analog and a PKA activator.
Host
Item no.	DCC-DC8388-1g
Amount	1 g
Available

Mavatrep(JNJ-39439335)

Type	Chemicals
Clone
Specific against	Other
Appl.	Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 μM) of CYP isoforms 3A4, 1A2, and 2D6.
Host
Item no.	DCC-DC8378-100mg
Amount	100 mg
Available

Mavatrep(JNJ-39439335)

Type	Chemicals
Clone
Specific against	Other
Appl.	Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 μM) of CYP isoforms 3A4, 1A2, and 2D6.
Host
Item no.	DCC-DC8378-250mg
Amount	250 mg
Available

Molecules

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Molecules

Contact

About Hölzel

Service

Infodesk